Compile Data Set for Download or QSAR
Report error Found 164 Enz. Inhib. hit(s) with all data for entry = 13350
TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Mouse)
Aeovian Pharmaceuticals

US Patent
LigandPNGBDBM783081((R)-6-(1H-Imidazol-1-yl)-4-methyl-N-(tetrahydro-2H...)
Affinity DataIC50: 1nMAssay Description:Required reaction buffer, required CD38 concentration in reaction buffer and required e-NAD concentration in reaction buffer were prepared. Thereafte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Mouse)
Aeovian Pharmaceuticals

US Patent
LigandPNGBDBM783105((R)-N-(1,1-Dioxidotetrahydrothiophen-3-yl)-2-(1H-i...)
Affinity DataIC50: 1nMAssay Description:Required reaction buffer, required CD38 concentration in reaction buffer and required e-NAD concentration in reaction buffer were prepared. Thereafte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Mouse)
Aeovian Pharmaceuticals

US Patent
LigandPNGBDBM783103((R)-N-(5,5-Difluorotetrahydro-2H-pyran-3-yl)-6-(1H...)
Affinity DataIC50: 1nMAssay Description:Required reaction buffer, required CD38 concentration in reaction buffer and required e-NAD concentration in reaction buffer were prepared. Thereafte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Mouse)
Aeovian Pharmaceuticals

US Patent
LigandPNGBDBM783109(6-(1H-Imidazol-1-yl)-4-methyl-N-(1-((tetrahydrofur...)
Affinity DataIC50: 1nMAssay Description:Required reaction buffer, required CD38 concentration in reaction buffer and required e-NAD concentration in reaction buffer were prepared. Thereafte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Mouse)
Aeovian Pharmaceuticals

US Patent
LigandPNGBDBM783108((R)-N-(4,4-Difluorotetrahydro-2H-pyran-3-yl)-6-(1H...)
Affinity DataIC50: 1nMAssay Description:Required reaction buffer, required CD38 concentration in reaction buffer and required e-NAD concentration in reaction buffer were prepared. Thereafte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Mouse)
Aeovian Pharmaceuticals

US Patent
LigandPNGBDBM783098(2-(1H-Imidazol-1-yl)-6-methyl-N-(1-(methylsulfonyl...)
Affinity DataIC50: 1nMAssay Description:Required reaction buffer, required CD38 concentration in reaction buffer and required e-NAD concentration in reaction buffer were prepared. Thereafte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Mouse)
Aeovian Pharmaceuticals

US Patent
LigandPNGBDBM783106((R)-2-(1H-Imidazol-1-yl)-6-methyl-N-(tetrahydro-2H...)
Affinity DataIC50: 1nMAssay Description:Required reaction buffer, required CD38 concentration in reaction buffer and required e-NAD concentration in reaction buffer were prepared. Thereafte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Mouse)
Aeovian Pharmaceuticals

US Patent
LigandPNGBDBM783065(N-(2,2-Dimethyltetrahydro-2H-pyran-4-yl)-6-(1H-imi...)
Affinity DataIC50: 5.5nMAssay Description:Required reaction buffer, required CD38 concentration in reaction buffer and required e-NAD concentration in reaction buffer were prepared. Thereafte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Mouse)
Aeovian Pharmaceuticals

US Patent
LigandPNGBDBM783064(N-(1,1-Dioxidotetrahydrothiophen-3-yl)-6-(1H-imida...)
Affinity DataIC50: 5.5nMAssay Description:Required reaction buffer, required CD38 concentration in reaction buffer and required e-NAD concentration in reaction buffer were prepared. Thereafte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Mouse)
Aeovian Pharmaceuticals

US Patent
LigandPNGBDBM783063(6-(1H-Imidazol-1-yl)-4-methyl-N-(1-(methylcarbamoy...)
Affinity DataIC50: 5.5nMAssay Description:Required reaction buffer, required CD38 concentration in reaction buffer and required e-NAD concentration in reaction buffer were prepared. Thereafte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Mouse)
Aeovian Pharmaceuticals

US Patent
LigandPNGBDBM783062(N-(1-(Dimethylcarbamoyl)piperidin-4-yl)-6-(1H-imid...)
Affinity DataIC50: 5.5nMAssay Description:Required reaction buffer, required CD38 concentration in reaction buffer and required e-NAD concentration in reaction buffer were prepared. Thereafte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Mouse)
Aeovian Pharmaceuticals

US Patent
LigandPNGBDBM783069(N-(8-Oxabicyclo[3.2.1]octan-3-yl)-6-(1H-imidazol-1...)
Affinity DataIC50: 5.5nMAssay Description:Required reaction buffer, required CD38 concentration in reaction buffer and required e-NAD concentration in reaction buffer were prepared. Thereafte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Mouse)
Aeovian Pharmaceuticals

US Patent
LigandPNGBDBM783067(N-(5,5-Difluorotetrahydro-2H-pyran-3-yl)-6-(1H-imi...)
Affinity DataIC50: 5.5nMAssay Description:Required reaction buffer, required CD38 concentration in reaction buffer and required e-NAD concentration in reaction buffer were prepared. Thereafte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Mouse)
Aeovian Pharmaceuticals

US Patent
LigandPNGBDBM783066(N-(4,4-Difluorotetrahydro-2H-pyran-3-yl)-6-(1H-imi...)
Affinity DataIC50: 5.5nMAssay Description:Required reaction buffer, required CD38 concentration in reaction buffer and required e-NAD concentration in reaction buffer were prepared. Thereafte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Mouse)
Aeovian Pharmaceuticals

US Patent
LigandPNGBDBM783057(6-(1H-Imidazol-1-yl)-4-methoxy-N-(1-(methylsulfony...)
Affinity DataIC50: 5.5nMAssay Description:Required reaction buffer, required CD38 concentration in reaction buffer and required e-NAD concentration in reaction buffer were prepared. Thereafte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Mouse)
Aeovian Pharmaceuticals

US Patent
LigandPNGBDBM783056(6-(1H-Imidazol-1-yl)-4-methyl-N-(1-(N-methylsulfam...)
Affinity DataIC50: 5.5nMAssay Description:Required reaction buffer, required CD38 concentration in reaction buffer and required e-NAD concentration in reaction buffer were prepared. Thereafte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Mouse)
Aeovian Pharmaceuticals

US Patent
LigandPNGBDBM783055(N-(1-Butyrylpiperidine-4-yl)-6-(1H-imidazol-1-yl)-...)
Affinity DataIC50: 5.5nMAssay Description:Required reaction buffer, required CD38 concentration in reaction buffer and required e-NAD concentration in reaction buffer were prepared. Thereafte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Mouse)
Aeovian Pharmaceuticals

US Patent
LigandPNGBDBM783119(6-(1H-Imidazol-1-yl)-N-(1-(methylsulfonyl)piperidi...)
Affinity DataIC50: 5.5nMAssay Description:Required reaction buffer, required CD38 concentration in reaction buffer and required e-NAD concentration in reaction buffer were prepared. Thereafte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Mouse)
Aeovian Pharmaceuticals

US Patent
LigandPNGBDBM783054(N-Cyclobutyl-6-(1H-imidazol-1-yl)-4-methylpicolina...)
Affinity DataIC50: 5.5nMAssay Description:Required reaction buffer, required CD38 concentration in reaction buffer and required e-NAD concentration in reaction buffer were prepared. Thereafte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Mouse)
Aeovian Pharmaceuticals

US Patent
LigandPNGBDBM783061(6-(1H-Imidazol-1-yl)-N-(1-(3-methoxypropanoyl)pipe...)
Affinity DataIC50: 5.5nMAssay Description:Required reaction buffer, required CD38 concentration in reaction buffer and required e-NAD concentration in reaction buffer were prepared. Thereafte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Mouse)
Aeovian Pharmaceuticals

US Patent
LigandPNGBDBM783060(6-(1H-Imidazol-1-yl)-4-methyl-N-(1-(2-morpholinoac...)
Affinity DataIC50: 5.5nMAssay Description:Required reaction buffer, required CD38 concentration in reaction buffer and required e-NAD concentration in reaction buffer were prepared. Thereafte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Mouse)
Aeovian Pharmaceuticals

US Patent
LigandPNGBDBM783124(6-(1H-Imidazol-1-yl)-4-methyl-N-(1-(oxetan-3-ylsul...)
Affinity DataIC50: 5.5nMAssay Description:Required reaction buffer, required CD38 concentration in reaction buffer and required e-NAD concentration in reaction buffer were prepared. Thereafte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Mouse)
Aeovian Pharmaceuticals

US Patent
LigandPNGBDBM783059(N-(1-(N,N-Dimethylsulfamoyl)piperidin-4-yl)-6-(1H-...)
Affinity DataIC50: 5.5nMAssay Description:Required reaction buffer, required CD38 concentration in reaction buffer and required e-NAD concentration in reaction buffer were prepared. Thereafte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Mouse)
Aeovian Pharmaceuticals

US Patent
LigandPNGBDBM783123((R)-N-(1,1-Dioxidotetrahydrothiophen-3-yl)-6-(1H-i...)
Affinity DataIC50: 5.5nMAssay Description:Required reaction buffer, required CD38 concentration in reaction buffer and required e-NAD concentration in reaction buffer were prepared. Thereafte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Mouse)
Aeovian Pharmaceuticals

US Patent
LigandPNGBDBM783058(6-(1H-Imidazol-1-yl)-N-(1-(methylsulfonyl)piperidi...)
Affinity DataIC50: 5.5nMAssay Description:Required reaction buffer, required CD38 concentration in reaction buffer and required e-NAD concentration in reaction buffer were prepared. Thereafte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Mouse)
Aeovian Pharmaceuticals

US Patent
LigandPNGBDBM783080(tert-Butyl (R)-3-(6-(1H-imidazol-1-yl)-4-methylpic...)
Affinity DataIC50: 5.5nMAssay Description:Required reaction buffer, required CD38 concentration in reaction buffer and required e-NAD concentration in reaction buffer were prepared. Thereafte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Mouse)
Aeovian Pharmaceuticals

US Patent
LigandPNGBDBM783079((R)-6-(1H-Imidazol-1-yl)-4-methyl-N-(tetrahydrofur...)
Affinity DataIC50: 5.5nMAssay Description:Required reaction buffer, required CD38 concentration in reaction buffer and required e-NAD concentration in reaction buffer were prepared. Thereafte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Mouse)
Aeovian Pharmaceuticals

US Patent
LigandPNGBDBM783084(tert-Butyl (S)-3-(6-(1H-imidazol-1-yl)-4-methylpic...)
Affinity DataIC50: 5.5nMAssay Description:Required reaction buffer, required CD38 concentration in reaction buffer and required e-NAD concentration in reaction buffer were prepared. Thereafte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Mouse)
Aeovian Pharmaceuticals

US Patent
LigandPNGBDBM783083((S)-6-(1H-imidazol-1-yl)-4-methyl-N-(1-(methylsulf...)
Affinity DataIC50: 5.5nMAssay Description:Required reaction buffer, required CD38 concentration in reaction buffer and required e-NAD concentration in reaction buffer were prepared. Thereafte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Mouse)
Aeovian Pharmaceuticals

US Patent
LigandPNGBDBM783082((S)-6-(1H-Imidazol-1-yl)-4-methyl-N-(tetrahydro-2H...)
Affinity DataIC50: 5.5nMAssay Description:Required reaction buffer, required CD38 concentration in reaction buffer and required e-NAD concentration in reaction buffer were prepared. Thereafte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Mouse)
Aeovian Pharmaceuticals

US Patent
LigandPNGBDBM783073(6-(1H-Imidazol-1-yl)-4-methyl-N-(tetrahydro-2H-pyr...)
Affinity DataIC50: 5.5nMAssay Description:Required reaction buffer, required CD38 concentration in reaction buffer and required e-NAD concentration in reaction buffer were prepared. Thereafte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Mouse)
Aeovian Pharmaceuticals

US Patent
LigandPNGBDBM783072(N-(3-Oxabicyclo[3.1.0]hexan-6-yl)-6-(1H-imidazol-1...)
Affinity DataIC50: 5.5nMAssay Description:Required reaction buffer, required CD38 concentration in reaction buffer and required e-NAD concentration in reaction buffer were prepared. Thereafte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Mouse)
Aeovian Pharmaceuticals

US Patent
LigandPNGBDBM783071(6-(1H-Imidazol-1-yl)-4-methyl-N-(2-methyltetrahydr...)
Affinity DataIC50: 5.5nMAssay Description:Required reaction buffer, required CD38 concentration in reaction buffer and required e-NAD concentration in reaction buffer were prepared. Thereafte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Mouse)
Aeovian Pharmaceuticals

US Patent
LigandPNGBDBM783070(N-(6,6-Dimethyltetrahydro-2H-pyran-3-yl)-6-(1H-imi...)
Affinity DataIC50: 5.5nMAssay Description:Required reaction buffer, required CD38 concentration in reaction buffer and required e-NAD concentration in reaction buffer were prepared. Thereafte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Mouse)
Aeovian Pharmaceuticals

US Patent
LigandPNGBDBM783077((S)-6-(1H-Imidazol-1-yl)-4-methyl-N-(tetrahydrofur...)
Affinity DataIC50: 5.5nMAssay Description:Required reaction buffer, required CD38 concentration in reaction buffer and required e-NAD concentration in reaction buffer were prepared. Thereafte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Mouse)
Aeovian Pharmaceuticals

US Patent
LigandPNGBDBM783076(N-(1,1-Dioxidotetrahydro-2H-thiopyran-3-yl)-6-(1H-...)
Affinity DataIC50: 5.5nMAssay Description:Required reaction buffer, required CD38 concentration in reaction buffer and required e-NAD concentration in reaction buffer were prepared. Thereafte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Mouse)
Aeovian Pharmaceuticals

US Patent
LigandPNGBDBM783075(N-(3,3-Difluorocyclopentyl)-6-(1H-imidazol-1-yl)-4...)
Affinity DataIC50: 5.5nMAssay Description:Required reaction buffer, required CD38 concentration in reaction buffer and required e-NAD concentration in reaction buffer were prepared. Thereafte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Mouse)
Aeovian Pharmaceuticals

US Patent
LigandPNGBDBM783074(N-Cycloheptyl-6-(1H-imidazol-1-yl)-4-methylpicolin...)
Affinity DataIC50: 5.5nMAssay Description:Required reaction buffer, required CD38 concentration in reaction buffer and required e-NAD concentration in reaction buffer were prepared. Thereafte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Mouse)
Aeovian Pharmaceuticals

US Patent
LigandPNGBDBM783097((S)-6-(1H-Imidazol-1-yl)-4-methyl-N-(2-oxopiperidi...)
Affinity DataIC50: 5.5nMAssay Description:Required reaction buffer, required CD38 concentration in reaction buffer and required e-NAD concentration in reaction buffer were prepared. Thereafte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Mouse)
Aeovian Pharmaceuticals

US Patent
LigandPNGBDBM783094((R)-N-(1,1-Dioxidotetrahydro-2H-thiopyran-3-yl)-6-...)
Affinity DataIC50: 5.5nMAssay Description:Required reaction buffer, required CD38 concentration in reaction buffer and required e-NAD concentration in reaction buffer were prepared. Thereafte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Mouse)
Aeovian Pharmaceuticals

US Patent
LigandPNGBDBM783101((R)-N-(6,6-Dimethyltetrahydro-2H-pyran-3-yl)-6-(1H...)
Affinity DataIC50: 5.5nMAssay Description:Required reaction buffer, required CD38 concentration in reaction buffer and required e-NAD concentration in reaction buffer were prepared. Thereafte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Mouse)
Aeovian Pharmaceuticals

US Patent
LigandPNGBDBM783099((R)-6-(1H-imidazol-1-yl)-N-(tetrahydro-2H-pyran-3-...)
Affinity DataIC50: 5.5nMAssay Description:Required reaction buffer, required CD38 concentration in reaction buffer and required e-NAD concentration in reaction buffer were prepared. Thereafte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Mouse)
Aeovian Pharmaceuticals

US Patent
LigandPNGBDBM783087((S)-6-(1H-Imidazol-1-yl)-4-methyl-N-(1-(methylsulf...)
Affinity DataIC50: 5.5nMAssay Description:Required reaction buffer, required CD38 concentration in reaction buffer and required e-NAD concentration in reaction buffer were prepared. Thereafte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Mouse)
Aeovian Pharmaceuticals

US Patent
LigandPNGBDBM783086(tert-Butyl (R)-3-(6-(1H-imidazol-1-yl)-4-methylpic...)
Affinity DataIC50: 5.5nMAssay Description:Required reaction buffer, required CD38 concentration in reaction buffer and required e-NAD concentration in reaction buffer were prepared. Thereafte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Mouse)
Aeovian Pharmaceuticals

US Patent
LigandPNGBDBM783092((S)-N-(1,1-Dioxidotetrahydrothiophen-3-yl)-6-(1H-i...)
Affinity DataIC50: 5.5nMAssay Description:Required reaction buffer, required CD38 concentration in reaction buffer and required e-NAD concentration in reaction buffer were prepared. Thereafte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Mouse)
Aeovian Pharmaceuticals

US Patent
LigandPNGBDBM783091((R)-6-(1H-Imidazol-1-yl)-4-methyl-N-(1-(methylsulf...)
Affinity DataIC50: 5.5nMAssay Description:Required reaction buffer, required CD38 concentration in reaction buffer and required e-NAD concentration in reaction buffer were prepared. Thereafte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Mouse)
Aeovian Pharmaceuticals

US Patent
LigandPNGBDBM783090((R)-6-(1H-Imidazol-1-yl)-4-methyl-N-(1-(methylsulf...)
Affinity DataIC50: 5.5nMAssay Description:Required reaction buffer, required CD38 concentration in reaction buffer and required e-NAD concentration in reaction buffer were prepared. Thereafte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Mouse)
Aeovian Pharmaceuticals

US Patent
LigandPNGBDBM783113((R)-2-(1H-Imidazol-1-yl)-N-(tetrahydro-2H-pyran-3-...)
Affinity DataIC50: 5.5nMAssay Description:Required reaction buffer, required CD38 concentration in reaction buffer and required e-NAD concentration in reaction buffer were prepared. Thereafte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Mouse)
Aeovian Pharmaceuticals

US Patent
LigandPNGBDBM783049(6-(1H-Imidazol-1-yl)-4-methyl-N-(1-(methylsulfonyl...)
Affinity DataIC50: 5.5nMAssay Description:Required reaction buffer, required CD38 concentration in reaction buffer and required e-NAD concentration in reaction buffer were prepared. Thereafte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Mouse)
Aeovian Pharmaceuticals

US Patent
LigandPNGBDBM783112(2-(1H-Imidazol-1-yl)-N-(1-(methylsulfonyl)piperidi...)
Affinity DataIC50: 5.5nMAssay Description:Required reaction buffer, required CD38 concentration in reaction buffer and required e-NAD concentration in reaction buffer were prepared. Thereafte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/11/2026
Entry Details
US Patent

Displayed 1 to 50 (of 164 total ) | Next | Last >>
Jump to: